Exploring the Application of Insect Based Drugs in the Treatment of Coronary Heart Disease Based on the Principle of “Networking for Communication”

As a common cardiovascular disease, patients with coronary heart disease (CHD) often have chest distress, chest pain, shortness of breath, panic, fatigue, sweating and other symptoms. The basic treatment plan in clinic is to prevent platelet aggregation, regulate lipid and stabilize plaque, and nourish myocardial cells; The theory of “using the network to facilitate communication” was proposed by Ye Tianshi and developed and perfected by Academician Wu Yiling, providing the treatment principle of “communication” for coronary heart disease; Insect drugs can treat CHD from multiple aspects, such as antithrombotic, anti-inflammatory, analgesic, immune regulation, anticoagulant, antioxidant, microcirculation improvement, and protection of vascular endothelial cells; Guided by the “collateral disease theory”, this paper discusses the relationship between “collateral for use” and coronary heart disease, insect drugs. From the four aspects of phlegm, blood stasis, wind, and deficiency, it discusses the pathogenesis of phlegm coagulating collaterals, blood stasis, internal movement of collateral wind, and stagnation of collateral deficiency. It establishes the treatment principles of coronary heart disease, which are phlegm resolving, blood stasis dispersing, wind dispelling, and qi flowing. Thus, it discusses the use of eight insect drugs, namely, ground beetle beetle, bombyx batrytica, scorpion, centipede, musk, earthworm, leech, and tabanus.